These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 15219820

  • 1. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.
    Salom JB, Pérez-Asensio FJ, Burguete MC, Marín N, Pitarch C, Torregrosa G, Romero FJ, Alborch E.
    Eur J Pharmacol; 2004 Jul 08; 495(1):55-62. PubMed ID: 15219820
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y, Li Q, Shuaib A.
    Exp Neurol; 2000 May 08; 163(1):39-45. PubMed ID: 10785442
    [Abstract] [Full Text] [Related]

  • 3. Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats.
    He M, Xing S, Yang B, Zhao L, Hua H, Liang Z, Zhou W, Zeng J, Pei Z.
    Brain Res; 2007 Nov 21; 1181():83-92. PubMed ID: 17920569
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of antioxidant and neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusion-induced oxidative stress in rats.
    Nazam Ansari M, Bhandari U, Islam F, Tripathi CD.
    Fundam Clin Pharmacol; 2008 Jun 21; 22(3):305-14. PubMed ID: 18485149
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats.
    Dhanarajan R, Abraham P, Isaac B.
    Basic Clin Pharmacol Toxicol; 2006 Sep 21; 99(3):267-72. PubMed ID: 16930301
    [Abstract] [Full Text] [Related]

  • 6. Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathion peroxidase.
    Puisieux F, Deplanque D, Bulckaen H, Maboudou P, Gelé P, Lhermitte M, Lebuffe G, Bordet R.
    Brain Res; 2004 Nov 19; 1027(1-2):30-7. PubMed ID: 15494154
    [Abstract] [Full Text] [Related]

  • 7. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats.
    Burguete MC, Torregrosa G, Pérez-Asensio FJ, Castelló-Ruiz M, Salom JB, Gil JV, Alborch E.
    Eur J Neurosci; 2006 Feb 19; 23(3):703-10. PubMed ID: 16487152
    [Abstract] [Full Text] [Related]

  • 8. Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats.
    Yang DY, Pan HC, Yen YJ, Wang CC, Chuang YH, Chen SY, Lin SY, Liao SL, Raung SL, Wu CW, Chou MC, Chiang AN, Chen CJ.
    Neurotoxicology; 2007 Nov 19; 28(6):1220-9. PubMed ID: 17854901
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
    Chauhan A, Sharma U, Jagannathan NR, Reeta KH, Gupta YK.
    Behav Brain Res; 2011 Dec 01; 225(2):603-9. PubMed ID: 21903138
    [Abstract] [Full Text] [Related]

  • 10. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Vakili A, Hosseinzadeh F, Sadogh T.
    Brain Res; 2007 Sep 19; 1170():97-102. PubMed ID: 17698046
    [Abstract] [Full Text] [Related]

  • 11. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression.
    Hoshida S, Aoki K, Nishida M, Yamashita N, Igarashi J, Hori M, Kuzuya T, Tada M.
    J Pharmacol Exp Ther; 1997 Jun 19; 281(3):1471-5. PubMed ID: 9190885
    [Abstract] [Full Text] [Related]

  • 12. Effect of vineatrol in focal cerebral ischemia in rats.
    Briyal S, Sharma U, Jagannathan NR, Gupta YK.
    Methods Find Exp Clin Pharmacol; 2009 Oct 19; 31(8):505-11. PubMed ID: 19967099
    [Abstract] [Full Text] [Related]

  • 13. Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: beneficial effects of 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6).
    Jiménez-Altayó F, Caracuel L, Pérez-Asensio FJ, Martínez-Revelles S, Messeguer A, Planas AM, Vila E.
    J Pharmacol Exp Ther; 2009 Nov 19; 331(2):429-36. PubMed ID: 19692633
    [Abstract] [Full Text] [Related]

  • 14. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
    Sayeed I, Guo Q, Hoffman SW, Stein DG.
    Ann Emerg Med; 2006 Apr 19; 47(4):381-9. PubMed ID: 16546625
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
    Foster KA, Regan HK, Danziger AP, Detwiler T, Kwon N, Rickert K, Lynch JJ, Regan CP.
    Neurosci Res; 2009 Jan 19; 63(1):10-6. PubMed ID: 18951929
    [Abstract] [Full Text] [Related]

  • 16. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
    Burger ME, Fachinetto R, Zeni G, Rocha JB.
    Pharmacol Biochem Behav; 2005 Jul 19; 81(3):608-15. PubMed ID: 15953628
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes.
    Seo JY, Lee CH, Cho JH, Choi JH, Yoo KY, Kim DW, Park OK, Li H, Choi SY, Hwang IK, Won MH.
    J Neurol Sci; 2009 Oct 15; 285(1-2):88-94. PubMed ID: 19576596
    [Abstract] [Full Text] [Related]

  • 18. Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat.
    Jiang N, Finklestein SP, Do T, Caday CG, Charette M, Chopp M.
    J Neurol Sci; 1996 Aug 15; 139(2):173-9. PubMed ID: 8856649
    [Abstract] [Full Text] [Related]

  • 19. Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection.
    Amantea D, Marrone MC, Nisticò R, Federici M, Bagetta G, Bernardi G, Mercuri NB.
    Int Rev Neurobiol; 2009 Aug 15; 85():363-74. PubMed ID: 19607981
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage.
    Prigol M, Wilhelm EA, Schneider CC, Nogueira CW.
    Chem Biol Interact; 2008 Nov 25; 176(2-3):129-36. PubMed ID: 18722362
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.